在COVID-19危急病患者的口服メラトニン:一个准实验的实用试验
Miguel Sánchez-García1,2, Jesús A F Tresguerres2,3, Manuel Álvarez-González1
1Department of Critical Care, Hospital Clínico San Carlos, Madrid, Spain.
Journal of medical virology
|January 14, 2026
概括
高剂量黑激素 (OBM) 在重症COVID-19患者中显著降低了90天死亡率. 这项研究发现OBM是安全有效的,改善了临床结果并减少了器官衰竭得分.
科学领域:
- 临界护理医学 临界护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 黑色素具有抗氧化,抗炎和潜在的抗病毒特性.
- 黑激素在重症COVID-19患者的治疗作用在疫情开始时还不清楚.
- 重症监护室 (ICU) 设置在治疗严重感染方面面临着独特的挑战.
研究的目的:
- 为了评估高剂量口服睡前黑激素 (OBM) 在重症COVID-19患者的疗效和安全性.
- 评估OBM对90天死亡率和器官功能的影响.
- 调查与OBM治疗相关的严重不良事件 (SAE) 的发生率.
主要方法:
- 一个准实验性的,务实的研究设计,交替控制和治疗期.
- 患者仅接受标准护理 (SoC) (控制) 或SoC加高剂量口服睡前黑激素 (50-200毫克) (治疗).
- 主要终点:90天死亡率. 二次结果:顺序性器官衰竭评估 (SOFA) 评分和SAE.
主要成果:
- 黑色素治疗与90天死亡率 (20.8%与36.1%) 的显著降低有关.
- 接受OBM治疗的患者在第4天和随后的访问中显示出较低的SOFA得分.
- 在OBM组中,SAE的发生频率较低 (41.6%对60.2%),这表明安全性较好.
结论:
- 高剂量口服黑激素是安全的,并且与重症COVID-19患者的改善临床结果有关.
- 黑素在降低死亡率和改善器官功能方面显示出潜在的益处.
- 对黑的抗病毒作用进行进一步的研究是有必要的,以应对未来的流行病.
相关概念视频
Management of Insomnia
528
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
528
Sedatives and Hypnotics Drugs: Miscellaneous Agents
508
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
508


